Ascendis Pharma - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAscendis Pharma

Ascendis Pharma(ASND)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Skytrofa	Lonapegsomatropin	2021-08-25		Growth and development
Skytrofa (previously lonapegsomatropin ascendis pharma)	Lonapegsomatropin	2022-01-11		Growth and development

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Lonapegsomatropin

healthy volunteers/patients

,

,

pituitary dwarfism

,

endocrine system diseases

,

failure to thrive

,

turner syndrome

,

pituitary diseases

,

sex chromosome disorders

,

chromosome disorders

,

noonan syndrome

,

,

sex chromosome disorders of sex development

Palopegteriparatide

endocrine system diseases

,

parathyroid diseases

,

hypoparathyroidism

,

,

atopic dermatitis

,

myeloid leukemia acute

,

multiple myeloma

,

,

plasma cell neoplasms

,

large b-cell lymphoma diffuse

,

type 2 diabetes mellitus

,

diabetes mellitus

,

,

opioid-related disorders

,

alzheimer disease

,

huntington disease

,

,

,

b-cell chronic lymphocytic leukemia

,

lymphoid leukemia

,

,

,

,

,

triple negative breast neoplasms

,

serogroup b neisseria meningitidis

,

,

urologic neoplasms

,

urinary bladder neoplasms

,

urologic diseases

,

urinary bladder diseases

,

,

,

cognitive dysfunction

,

central nervous system neoplasms

,

solitary fibrous tumors

,

neurofibromatosis 1

,

neurofibromatoses

,

hemangioblastoma

,

hemangiopericytoma

,

,

streptococcal infections

,

thyroid neoplasms

,

thyroid diseases

,

,

breast neoplasms

,

sickle cell anemia

,

,

renal insufficiency

,

,

,

rheumatoid arthritis

,

,

bacterial pneumonia

,

juvenile arthritis

,

psoriatic arthritis

,

ankylosing spondylitis

,

carotid artery diseases

,

atherosclerosis

,

ulcerative colitis

,

,

meningococcal meningitis

,

,

thromboembolism

,

,

,

acquired immunodeficiency syndrome

,

immune reconstitution inflammatory syndrome

,

,

alopecia areata

,

,

,

healthy volunteers/patients

,

,

communicable diseases

,

intraabdominal infections

,

smoking cessation

,

neuroendocrine tumors

,

islet cell adenoma

,

psychomotor agitation

,

,

renal cell carcinoma

,

,

gaucher disease

,

tobacco use disorder

,

,

hypersensitivity

,

peanut hypersensitivity

renal cell carcinoma

,

,

non-small-cell lung carcinoma

,

endometrial neoplasms

,

hepatocellular carcinoma

,

stomach neoplasms

,

,

liver neoplasms

,

,

gastrointestinal neoplasms

,

neuroendocrine tumors

,

type 2 diabetes mellitus

,

diabetes mellitus

,

,

glucose metabolism disorders

,

metabolic diseases

,

endocrine system diseases

,

breast neoplasms

non-small-cell lung carcinoma

,

squamous cell carcinoma of head and neck

,

,

,

triple negative breast neoplasms

,

renal cell carcinoma

,

,

colorectal neoplasms

,

urologic neoplasms

,

urinary bladder neoplasms

,

transitional cell carcinoma

,

prostatic neoplasms

,

hereditary nonpolyposis colorectal neoplasms

,

,

hepatocellular carcinoma

,

liver neoplasms

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use